NCT04921163

Brief Summary

Aluminium allergy is predominantly seen in children with small itchy nodules in the skin after vaccinations, so-called granulomas. We want to do an exposure study where aluminium allergic children have to eat aluminium pancakes for a short period of time. The purpose is to investigate whether a worsening of the children's symptoms can be detected, both itching of the granuloma, allergic rash on the skin and also the symptoms that are not measurable, such as headache, stomach ache and general agitation. We also want to examine the concentration of aluminium in the urine, which reflects the absorption of aluminum from the gastrointestinal tract.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 10, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2023

Enrollment Period

12 months

First QC Date

January 14, 2021

Last Update Submit

March 27, 2023

Conditions

Keywords

vaccination granulomaaluminiumcontact allergyexposure

Outcome Measures

Primary Outcomes (3)

  • granuloma

    itch of existing granuloma evaluated on a Visual analogue scale 0-10

    1-7 days

  • skin

    flare-up of previous patch test area, evaluated on a visual scheme

    1-7 days

  • subjective

    headache, irritability, stomach ache evaluated on an adapted visual analogue scale 0-10

    1-7 days

Secondary Outcomes (1)

  • sleep

    1-7 days

Study Arms (3)

aluminium

ACTIVE COMPARATOR

4-day test periode with intake of aluminium pancakes

Dietary Supplement: sodium aluminium phospate (SALP)

placebo

PLACEBO COMPARATOR

4-day test periode with aluminium-free pancakes

Dietary Supplement: Aluminium-free pancake

second placebo

PLACEBO COMPARATOR

Again a 4-day test periode with aluminium-free pancakes

Dietary Supplement: Aluminium-free pancake

Interventions

1 pancake daily for 4 days

aluminium
Aluminium-free pancakeDIETARY_SUPPLEMENT

1 pancake daily for 4 days, without aluminium

placebosecond placebo

Eligibility Criteria

Age1 Year - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children with contact allergies to aluminium, demonstrated by patch tests
  • Activity (itching) of the granulom within the last six months
  • Written consent obtained from all custodians

You may not qualify if:

  • a detected food allergy for the remaining products in the pancakes (including wheat flour, eggs and milk)
  • Children treated with topical and/or systemic steroid preparations during and up to 1 week before the start of the study.
  • Children treated with systemic immune suppression during and up to 1 week before the start of the study.
  • Children with kidney or bone disease.
  • Children vaccinated during the study period
  • Treatment with acid neutralising medicines during and up to 1 week before the start of the study
  • Another reason for inability to cooperate, including lack of language skills in Danish or English in parents.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Allergy Research Centre

Hellerup, 2900, Denmark

Location

MeSH Terms

Conditions

Dermatitis, ContactDermatitis, Allergic Contact

Condition Hierarchy (Ancestors)

DermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, EczematousHypersensitivity, DelayedHypersensitivityImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: double blinded cross over study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, ph.d. student

Study Record Dates

First Submitted

January 14, 2021

First Posted

June 10, 2021

Study Start

June 1, 2021

Primary Completion

May 15, 2022

Study Completion

June 15, 2022

Last Updated

March 28, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations